Workflow
INSPIRE therapy
icon
Search documents
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
The Motley Fool· 2025-06-28 13:10
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global population and the rising prevalence of chronic diseases.Here are 10 under-the-radar healthcare stocks that could be great buys for your portfolio. 1. CertaraCertara (CERT -0.35%) is poised to capitalize on the transform ...
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
Globenewswire· 2025-06-03 12:00
Core Insights - Inspire Medical Systems, Inc. is a medical technology company specializing in innovative, minimally invasive solutions for obstructive sleep apnea [1][3] - The company will present at the Truist Securities MedTech Conference on June 17, 2025, at 11:20 a.m. Eastern Time, with a live webcast available [1][2] Company Overview - Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea [3] - The company focuses on the development and commercialization of its innovative solutions [3]
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
GlobeNewswire News Room· 2025-05-30 12:00
Core Insights - Inspire Medical Systems, Inc. is participating in the Wells Fargo 2025 MedTech Innovation Spotlight on June 13, 2025 [1][2] - The company specializes in minimally invasive solutions for obstructive sleep apnea, with its proprietary Inspire therapy being the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for this condition [3] Company Overview - Inspire Medical Systems focuses on the development and commercialization of innovative solutions for patients suffering from obstructive sleep apnea [3] - The Inspire therapy offers a safe and effective treatment option for moderate to severe obstructive sleep apnea [3] Presentation Details - The presentation by Inspire is scheduled for 12:00 p.m. Eastern Time and will be accessible via a live webcast [2] - A replay of the presentation will be available for two weeks in the Event Archive section of Inspire's Investor website [2]
Inspire(INSP) - 2025 Q1 - Earnings Call Transcript
2025-05-05 22:02
Inspire Medical Systems (INSP) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor RelationsTim Herbert - Chairman, President & CEORick Buchholz - CFOTravis Steed - Managing Director - Equity ResearchRichard Newitter - Managing DirectorChris Pasquale - Partner - Medical Devices & SuppliesAnthony Petrone - Managing DirectorJonathan Block - Managing DirectorBrett Gasaway - VP - Equity Research Conference Call Participants Danielle Antalffy - AnalystRober ...
Inspire(INSP) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:00
Inspire Medical Systems (INSP) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Speaker0 Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems First Quarter twenty twenty five Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers remarks, there'll be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. Y ...
Inspire(INSP) - 2025 Q1 - Earnings Call Presentation
2025-05-05 20:58
Inspire Medical Systems, Inc. May 2025 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''project,'' ''contemplate,'' ' ...
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
GlobeNewswire News Room· 2025-05-05 20:02
Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2025. Recent Business Highlights Generated revenue of $201.3 ...
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
Globenewswire· 2025-04-29 12:00
Core Insights - Inspire Medical Systems, Inc. is a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea [3] - The company will present at the BofA Securities 2025 Health Care Conference on May 13, 2025, at 2:20 p.m. Eastern Time [2] - Inspire's proprietary therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea [3] Company Information - Inspire focuses on the development and commercialization of innovative solutions for obstructive sleep apnea [3] - The company’s Inspire therapy is recognized for its safety and effectiveness in treating the condition [3] - Additional information about Inspire can be found on their official website [3]
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
Globenewswire· 2025-03-06 13:00
Company Overview - Inspire Medical Systems, Inc. is a medical technology company focused on developing and commercializing innovative, minimally invasive solutions for patients with obstructive sleep apnea [3]. - The company's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea [3]. Upcoming Presentation - Inspire is scheduled to present at the KeyBanc Capital Markets Healthcare Forum on March 18, 2025, at 3:00 p.m. Eastern Time [2]. - The presentation will be accessible via a live webcast, with a replay available for two weeks following the event in the Event Archive section of Inspire's Investor website [2].
Inspire(INSP) - 2024 Q4 - Earnings Call Transcript
2025-02-10 23:02
Inspire Medical Systems (INSP) Q4 2024 Earnings Call February 10, 2025 05:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor RelationsTimothy Herbert - Founder, Chairman, CEO & PresidentRichard Buchholz - Chief Financial OfficerTravis Steed - Managing Director - Equity ResearchChris Pasquale - Partner - Medical Devices & SuppliesAnthony Petrone - Managing DirectorRichard Newitter - Managing DirectorJonathan Block - Managing DirectorMike Kratky - Senior Managing Director, Medical Devices a ...